Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$37.53 - $44.22 $26,271 - $30,954
-700 Closed
0 $0
Q1 2022

Apr 14, 2022

SELL
$37.46 - $42.44 $490,726 - $555,964
-13,100 Reduced 94.93%
700 $1,000
Q2 2021

Jul 19, 2021

SELL
$39.85 - $46.63 $7,970 - $9,326
-200 Reduced 1.43%
13,800 $57,000
Q1 2021

Apr 26, 2021

BUY
$42.34 - $52.82 $558,888 - $697,224
13,200 Added 1650.0%
14,000 $70,000
Q4 2020

Jan 21, 2021

BUY
$36.12 - $50.05 $3,611 - $5,005
100 Added 14.29%
800 $0
Q3 2020

Oct 27, 2020

BUY
$38.56 - $48.36 $26,992 - $33,852
700 New
700 $0

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $13.8B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.